Status: Recruiting
Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device
Liquid biopsy is a noninvasive method for detecting and quantifying circulating tumor cells (CTCs). Thanks to ScreenCell technology, this study aims to evaluate the evolution of the number of CTCs during breast cancer follow-up. The identification and characterization of CTCs would make it possible to obtain information on the stage and molecular characteristics of cancer during follow-up
Participants needed: 93
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: ScreenCellUpdated: Apr 24, 2026Locations: 1
Eligibility criteria
Female with age greater than or equal to 18 years [+2]
Male [+6]